Literature DB >> 30463915

Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia.

Allyson M Pishko1, Sara Fardin2, Daniel S Lefler1, Koosha Paydary3, Rolando Vega1, Gowthami M Arepally4, Mark Crowther5, Lawrence Rice6, Douglas B Cines1,7, Adam Cuker1,7.   

Abstract

The HIT Expert Probability (HEP) score compared favorably with the 4Ts score in a retrospective study. We assessed the diagnostic accuracy of the HEP score compared with the 4Ts score in a prospective cohort of 310 patients with suspected heparin-induced thrombocytopenia (HIT). A member of the clinical team calculated the HEP score and 4Ts score. An independent panel adjudicated HIT status based on a clinical summary as well as the results of HIT laboratory testing. The prevalence of HIT in the study population was 14.7%. At a cutoff of ≥3, the HEP score was 95.3% sensitive (95% confidence interval [CI], 84.2-99.4) and 35.7% specific (95% CI, 29.8-42.0) for HIT. A 4Ts score of ≥4 had a sensitivity of 97.7% (95% CI, 86.2-99.8) and specificity of 32.9% (95% CI, 27.2-39.1). The areas under the receiver operating characteristic (ROC) curves (AUCs) for the HEP score and 4Ts score were similar (0.81 [95% CI, 0.74-0.87] vs 0.76 [95% CI, 0.69-0.83]; P = .12). The HEP score exhibited a significantly higher AUC than the 4Ts score in patients in the intensive care unit (ICU) (0.86 vs 0.79; P = .03). Among trainee scorers, the HEP score performed significantly better than the 4Ts score (AUC, 0.80 vs 0.73; P = .03). Our data suggest that either the 4Ts score or the HEP score may be used in clinical practice. The HEP score may be preferable in ICU patients and among less experienced clinicians.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30463915      PMCID: PMC6258908          DOI: 10.1182/bloodadvances.2018023077

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  18 in total

1.  Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.

Authors:  G K Lo; D Juhl; T E Warkentin; C S Sigouin; P Eichler; A Greinacher
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

2.  Prospective evaluation of the interobserver reliability of the 4Ts score in patients with suspected heparin-induced thrombocytopenia.

Authors:  M Nagler; T Fabbro; Walter A Wuillemin
Journal:  J Thromb Haemost       Date:  2012-01       Impact factor: 5.824

3.  Assessing screening tests: extensions of McNemar's test.

Authors:  P A Lachenbruch; C J Lynch
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

4.  External validation of the HIT Expert Probability (HEP) score.

Authors:  Lee Joseph; Marcelo P V Gomes; Firas Al Solaiman; Julie St John; Asuka Ozaki; Manjunath Raju; Manoj Dhariwal; Esther S H Kim
Journal:  Thromb Haemost       Date:  2015-01-15       Impact factor: 5.249

5.  Heparin-associated thrombocytopenia.

Authors:  D B Cines; P Kaywin; M Bina; A Tomaski; A D Schreiber
Journal:  N Engl J Med       Date:  1980-10-02       Impact factor: 91.245

Review 6.  Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis.

Authors:  Adam Cuker; Phyllis A Gimotty; Mark A Crowther; Theodore E Warkentin
Journal:  Blood       Date:  2012-09-18       Impact factor: 22.113

7.  Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range.

Authors:  A Greinacher; P Eichler; N Lubenow; H Kwasny; M Luz
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

Review 8.  Diagnostic accuracy of IgG-specific versus polyspecific enzyme-linked immunoassays in heparin-induced thrombocytopenia: a systematic review and meta-analysis.

Authors:  H D Husseinzadeh; P A Gimotty; A M Pishko; M Buckley; T E Warkentin; A Cuker
Journal:  J Thromb Haemost       Date:  2017-05-11       Impact factor: 5.824

9.  Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass.

Authors:  A Lillo-Le Louët; P Boutouyrie; M Alhenc-Gelas; C Le Beller; I Gautier; M Aiach; D Lasne
Journal:  J Thromb Haemost       Date:  2004-11       Impact factor: 5.824

10.  A diagnostic test for heparin-induced thrombocytopenia.

Authors:  D Sheridan; C Carter; J G Kelton
Journal:  Blood       Date:  1986-01       Impact factor: 22.113

View more
  11 in total

1.  Heparin induced thrombocytopenia: position paper from the Italian Society on Thrombosis and Haemostasis (SISET).

Authors:  Rossella Marcucci; Martina Berteotti; Anna M Gori; Betti Giusti; Angela A Rogolino; Elena Sticchi; Agatina Alessandrello Liotta; Walter Ageno; Erica De Candia; Paolo Gresele; Marina Marchetti; Marco Marietta; Armando Tripodi
Journal:  Blood Transfus       Date:  2020-12-28       Impact factor: 3.443

2.  The risk of major bleeding in patients with suspected heparin-induced thrombocytopenia.

Authors:  Allyson M Pishko; Daniel S Lefler; Phyllis Gimotty; Koosha Paydary; Sara Fardin; Gowthami M Arepally; Mark Crowther; Lawrence Rice; Rolando Vega; Douglas B Cines; James P Guevara; Adam Cuker
Journal:  J Thromb Haemost       Date:  2019-08-12       Impact factor: 5.824

3.  Heparin-induced thrombocytopenia and cardiovascular surgery.

Authors:  Allyson M Pishko; Adam Cuker
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

4.  Lower Limb Paralysis as Initial Presentation of Arterial Embolism Secondary to Heparin-Induced Thrombocytopenia after Hip Fracture - a Case Report.

Authors:  Petros Kapsetakis; Georgios Magarakis; Constantinos Chaniotakis; Phaedon D Zavras; Georgios Kavalaris; Christos Koutserimpas; Kalliopi Alpantaki
Journal:  Maedica (Bucur)       Date:  2022-06

5.  Soluble glycoprotein VI is a predictor of major bleeding in patients with suspected heparin-induced thrombocytopenia.

Authors:  Allyson M Pishko; Robert K Andrews; Elizabeth E Gardiner; Daniel S Lefler; Adam Cuker
Journal:  Blood Adv       Date:  2020-09-22

6.  Diagnosing HIT: the need for speed.

Authors:  Adam Cuker; Douglas B Cines
Journal:  Blood       Date:  2020-04-02       Impact factor: 25.476

Review 7.  Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management.

Authors:  Matteo Marchetti; Maxime G Zermatten; Debora Bertaggia Calderara; Alessandro Aliotta; Lorenzo Alberio
Journal:  J Clin Med       Date:  2021-02-10       Impact factor: 4.241

Review 8.  Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS.

Authors:  Emmanuel J Favaloro; Leonardo Pasalic; Giuseppe Lippi
Journal:  Antibodies (Basel)       Date:  2022-01-21

9.  Fondaparinux for systemic anticoagulation during continuous hemofiltration in a patient with heparin-induced thrombocytopenia and limb ischemia - a case report.

Authors:  Eduardo Atsushi Osawa; Antonio Adolfo Guerra Soares Brandão; André Dias Américo; Alexandre Toledo Maciel
Journal:  Hematol Transfus Cell Ther       Date:  2020-07-12

10.  Prediction of Heparin Induced Thrombocytopenia (HIT) Using a Combination of 4Ts Score and Screening Immune Assays.

Authors:  Rajat Thawani; Srikant Nannapaneni; Vivek Kumar; Phone Oo; Michael Simon; Anna Huang; Ishan Malhotra; Yiqing Xu
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.